These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 34556520)
1. Evaluating the efficacy of intranasal oxytocin on pain and function among individuals who experience chronic pain: a protocol for a multisite, placebo-controlled, blinded, sequential, within-subjects crossover trial. Rash JA; Campbell TS; Cooper L; Flusk D; MacInnes A; Nasr-Esfahani M; Mekhael AA; Poulin PA; Robert M; Yi Y BMJ Open; 2021 Sep; 11(9):e055039. PubMed ID: 34556520 [TBL] [Abstract][Full Text] [Related]
2. Protocol for a placebo-controlled, within-participants crossover trial evaluating the efficacy of intranasal oxytocin to improve pain and function among women with chronic pelvic musculoskeletal pain. Rash JA; Toivonen K; Robert M; Nasr-Esfahani M; Jarrell JF; Campbell TS BMJ Open; 2017 Apr; 7(4):e014909. PubMed ID: 28416501 [TBL] [Abstract][Full Text] [Related]
3. PRECISE trial (Pain RElief Combination Intervention StratEgies): protocol for the clinical trial of a pregabalin-melatonin combination for fibromyalgia. Gilron I; DeBow C; Elkerdawy H; Khan JS; Salomons TV; Duggan S; Tu D; Holden RR; Milev R; Buckley DN; Moulin DE BMJ Open; 2024 Jun; 14(6):e087180. PubMed ID: 38910006 [TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
5. Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM-CP): a study protocol. Adam R; Kanakarajan S; Onyeakazi U; Columb M; Galley H BMJ Open; 2020 Mar; 10(3):e034443. PubMed ID: 32184313 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of soothing cream gel in the range of motion and chronic pain at the shoulder and elbow: protocol of a double-blinded, randomised, placebo-controlled trial. Lo CW; Sum KWR; Leung FLE; Yang Y; Chan KL; Lam KK; Lau KW; Sum CH; Lin WL; Ho SH; Lin ZX BMJ Open; 2024 Jul; 14(7):e085856. PubMed ID: 38969378 [TBL] [Abstract][Full Text] [Related]
7. The effect of intranasal oxytocin on the perception of affective touch and multisensory integration in anorexia nervosa: protocol for a double-blind placebo-controlled crossover study. Crucianelli L; Serpell L; Paloyelis Y; Ricciardi L; Robinson P; Jenkinson P; Fotopoulou A BMJ Open; 2019 Mar; 9(3):e024913. PubMed ID: 30878983 [TBL] [Abstract][Full Text] [Related]
8. Internet-delivered attentional bias modification training (iABMT) for the management of chronic musculoskeletal pain: a protocol for a randomised controlled trial. Liossi C; Georgallis T; Zhang J; Hamilton F; White P; Schoth DE BMJ Open; 2020 Feb; 10(2):e030607. PubMed ID: 32086350 [TBL] [Abstract][Full Text] [Related]
9. Intranasal oxytocin as a treatment for chronic pelvic pain: A randomized controlled feasibility study. Flynn MJ; Campbell TS; Robert M; Nasr-Esfahani M; Rash JA Int J Gynaecol Obstet; 2021 Mar; 152(3):425-432. PubMed ID: 33112417 [TBL] [Abstract][Full Text] [Related]
10. Study protocol for a randomised, double-blinded, placebo-controlled, clinical trial of S-ketamine for pain treatment in patients with chronic pancreatitis (RESET trial). Juel J; Olesen SS; Olesen AE; Poulsen JL; Dahan A; Wilder-Smith O; Madzak A; Frøkjær JB; Drewes AM BMJ Open; 2015 Mar; 5(3):e007087. PubMed ID: 25757947 [TBL] [Abstract][Full Text] [Related]
11. Study protocol for a pilot, randomised, double-blinded, placebo controlled trial of perineural local anaesthetics and steroids for chronic post-traumatic neuropathic pain in the ankle and foot: the PREPLANS study. Bhatia A; Bril V; Brull RT; Perruccio A; Wijeysundera D; Alvi S; Lau J; Gandhi R; Mahomed N; Davis AM BMJ Open; 2016 Jun; 6(6):e012293. PubMed ID: 27334885 [TBL] [Abstract][Full Text] [Related]
12. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study. Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796 [TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
14. Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol. Matsuoka H; Clark K; Fazekas B; Oyamada S; Brown L; Ishiki H; Matsuda Y; Hasuo H; Ariyoshi K; Lee J; Le B; Allcroft P; Kochovska S; Fujiwara N; Miyaji T; Lovell M; Agar M; Yamaguchi T; Satomi E; Iwase S; Phillips J; Koyama A; Currow DC BMJ Open; 2022 Feb; 12(2):e050182. PubMed ID: 35131817 [TBL] [Abstract][Full Text] [Related]
15. Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS). Yamada S; Hashizume A; Hijikata Y; Inagaki T; Ito D; Kinoshita F; Nakatochi M; Kobayashi Y; Hirakawa A; Nakamura T; Katsuno M BMJ Open; 2018 Sep; 8(9):e023041. PubMed ID: 30206090 [TBL] [Abstract][Full Text] [Related]
16. Graded Exposure Therapy for Fear Avoidance Behaviour After Concussion (GET FAB): protocol for a multisite Canadian randomised controlled trial. Mikolic A; Klotz T; Brasher P; Yeates K; Vranceanu AM; Kendall KD; Snell DL; Debert CT; Bayley M; Panenka W; Cairncross M; Hunt C; Burke M; Tartaglia MC; Silverberg N; BMJ Open; 2024 Jul; 14(6):e086602. PubMed ID: 38950993 [TBL] [Abstract][Full Text] [Related]
17. Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study. Matsuoka H; Ishiki H; Iwase S; Koyama A; Kawaguchi T; Kizawa Y; Morita T; Matsuda Y; Miyaji T; Ariyoshi K; Yamaguchi T BMJ Open; 2017 Aug; 7(8):e017280. PubMed ID: 28851798 [TBL] [Abstract][Full Text] [Related]
18. Subdissociative intranasal ketamine plus standard pain therapy versus standard pain therapy in the treatment of paediatric sickle cell disease vaso-occlusive crises in resource-limited settings: study protocol for a randomised controlled trial. Young JR; Sawe HR; Mfinanga JA; Nshom E; Helm E; Moore CG; Runyon MS; Reynolds SL BMJ Open; 2017 Jul; 7(7):e017190. PubMed ID: 28698351 [TBL] [Abstract][Full Text] [Related]
19. ON-ICE trial: Investigation of the combined effects of oxytocin and naltrexone on stress-induced and alcohol cue-induced craving in alcohol use disorder-Study protocol of a phase II randomised double-blind placebo-controlled parallel-group trial. Zimmermann S; Thomas BC; Krisam J; Limprecht R; Klose C; Stenger M; Pourbaix M; Ries M; Vollstaedt-Klein S; Koopmann A; Lenz B; Kiefer F; Bach P BMJ Open; 2022 Apr; 12(4):e059672. PubMed ID: 35410938 [TBL] [Abstract][Full Text] [Related]
20. Antiepileptic drugs for chronic non-cancer pain in children and adolescents. Cooper TE; Wiffen PJ; Heathcote LC; Clinch J; Howard R; Krane E; Lord SM; Sethna N; Schechter N; Wood C Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012536. PubMed ID: 28779491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]